Phadia announced that the FDA has cleared the ImmunoCAP® Rapid Reader II, a part of the ImmunoCAP Rapid System, used to aid in the diagnosis of allergy in the physician’s office.
Read More
Sequenom Inc announced the launch of the SensiGene™ Fetal RHD Genotyping test by Sequenom’s CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM). This is the company’s first laboratory developed test powered by its SEQureDx technology.
Read MoreA new diagnostic tool from Abbott that physicians can use to monitor patients for the most common form of ovarian cancer may soon be available in the United States.
Read More
This month’s Product Features and Benefits is available as a downloadable pdf – you will need Adobe Acrobat reader to view this. If you do not have Adobe Acrobat on your computer, you can download it for free from Adobe.com.
Read More